Breakthrough detection: Mayo Clinic’s REDMOD AI identified pancreatic cancer up to 36 months before diagnosis, outperforming radiologists in early-stage detection. Why timing matters: Pancreatic ...

Mayo Clinic's AI model identifies invisible signs of pancreatic cancer on routine CT scans, potentially transforming early ...

A new study led by NYU Langone Health researchers has found that cancer cells are better able to resist treatments when they ...

Loss of an enzyme necessary for a process called lipoylation disrupts the way cancer cells copy their DNA, increasing their ...

US drug pricing policy and Congressional Budget Office (CBO) model of the Build Back Better Act examining pharmaceutical R&D ...

While cancer imaging AI is advancing, it still requires validation, infrastructure, and industry support for wider clinical ...

AI interaction," say researchers who tested OpenAI's latest LLM preview. Meanwhile, a Mayo Clinic model diagnosed pancreatic ...

The model is already live with early pharma partners Amgen and AstraZeneca. An AstraZeneca-sponsored Phase 2 trial is ...

First patient ever treated with Alpha DaRT for pancreatic cancer in Italy, under a clinical study conducted at the world-renowned Pancreas ...

CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, /PRNewswire/ -- Harbour BioMed (the 'Company'; HKEX: 02142), a global ...

The oral presentation, titled, “¹⁸⁶Rhenium-Nanoliposomes (¹⁸⁶RNL) for the Treatment of Leptomeningeal Metastases: Translational Insights from Clinical and Preclinical Models,” was delivered by ...